Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Introgen Therapeutics, Inc. (INGN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: INGN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
Feb 13
•
EP Vantage
•
Comment!
FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
Aug 7, 2008
•
Mike Havrilla
•
2 Comments
Introgen Therapeutics: Advexin's P-Value Borg - Resistance is Futile
Jun 4, 2008
•
The Biotech Onion
•
6 Comments
Cancer Stocks: Tracking the Market
Jul 9, 2007
•
Alan Brochstein
•
Comment!
Introgen Hints At Cancer Gene Therapy Lawsuit Against Benda
Jul 6, 2007
•
ChinaBio Today
•
Comment!
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
3 Comments
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
3 Comments
Introgen Therapeutics: Empty Promises For Cancer Patients and Shareholders
Apr 23, 2007
•
10Q Detective
•
Comment!
Introgen Reports Positive Result in FUS1 Clinical Trial
Apr 18, 2007
•
SA Editor Judith Levy
•
Comment!
Why Introgen is a Terminal Case
Mar 12, 2007
•
PharmaTracker
•
Comment!
Unanswered Questions Support a Short Position in Introgen
Mar 5, 2007
•
Charles Atan
•
Comment!
Introgen: Setting The Record Straight On Its Biomarker Claims
Feb 27, 2007
•
Charles Atan
•
Comment!
Why Keeping Money in Introgen is a Fool's Game
Feb 20, 2007
•
Kevin McNamara
•
Comment!
Biotech Stocks Day In Review: Will Sanofi-Aventis Merge With Bristol-Myers Squibb?
Jan 30, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Stocks Day-in-Review: Genentech Beats Estimates
Jan 11, 2007
•
Centient Biotech Investor
•
Comment!